Edition:
India

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

26.26CNY
22 Jun 2018
Change (% chg)

¥0.21 (+0.81%)
Prev Close
¥26.05
Open
¥25.97
Day's High
¥26.33
Day's Low
¥25.28
Volume
9,747,491
Avg. Vol
12,614,154
52-wk High
¥34.22
52-wk Low
¥23.15

Latest Key Developments (Source: Significant Developments)

Tasly Pharmaceutical Group to pay FY 2017 annual div on June 5
Tuesday, 29 May 2018 

May 29(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS> ::Says it plans to pay FY 2017 dividend to shareholders of record on June 4.The company's shares will be traded ex-right and ex-dividend on June 5 and the dividend will be paid on June 5.  Full Article

Tasly Pharmaceutical Group issues 2018 first tranche medium-term notes worth 1 bln yuan
Monday, 7 May 2018 

May 7(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it issued 2018 first tranche medium-term notes worth 1 billion yuan, with a term of three years and an interest rate of 5.39 percent .  Full Article

Tasly Pharmaceutical Group elects chairman, appoints general manager and CFO
Tuesday, 17 Apr 2018 

April 17(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it elects Yan Kaijing as chairman, appoints Zhu Yonghong as general manager and Li Jinyuan as chief financial officer.  Full Article

Tasly Pharmaceutical Says Its Q1 Net Profit Up 16.77 Percent Y/Y
Monday, 16 Apr 2018 

April 16 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>::SAYS ITS Q1 NET PROFIT UP 16.77 PERCENT Y/Y AT 371.5 MILLION YUAN ($59.14 million).  Full Article

Tasly Pharmaceutical Group announces 2017 dividend payment
Tuesday, 27 Mar 2018 

March 27(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it plans to pay a cash dividend of 4.00 yuan (pre-tax) per 10 shares to shareholders for 2017, and use additional paid-in capital to distribute four new shares for every 10 shares.  Full Article

BRIEF-Tasly Pharmaceutical Group Says 2017 Net Profit Up 17.0 Percent Y/Y
Monday, 26 Mar 2018 

Refiles with correct link:SAYS 2017 NET PROFIT UP 17.0 PERCENT Y/Y.  Full Article

Tasly Pharmaceutical's 9-month net profit up 13.5 pct y/y
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says 9-month net profit up 13.5 percent y/y.  Full Article

Tasly Pharmaceutical Group unit gets nod for clinic trial
Monday, 15 Aug 2016 

Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says its unit gets China Food and Drug Administration's approval for an injection's clinic trial.  Full Article

Tasly Pharma's H1 net profit down 17.5 pct
Friday, 12 Aug 2016 

Tasly Pharmaceutical Group Co Ltd <600535.SS> :Says H1 net profit down 17.5 percent y/y at 684.8 million yuan ($103.06 million).  Full Article

BRIEF-Tasly Pharmaceutical Plans To Issue Up To 2.0 Billion Yuan Medium-Term Notes

* SAYS IT PLANS TO ISSUE UP TO 2.0 BILLION YUAN ($307.36 million) MEDIUM-TERM NOTES Source text in Chinese: http://bit.ly/2C6wiFx Further company coverage: ($1 = 6.5070 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)